VMS stands for vasomotor symptoms, the medical term for hot flashes and night sweats during menopause. They’re considered the hallmark symptom of the menopausal transition, and more than half of midlife women experience them. While often dismissed as a temporary inconvenience, VMS typically last far longer than most people expect and can signal meaningful changes in long-term health.
What VMS Feel Like
A vasomotor symptom is an episode of sudden, intense heat accompanied by sweating and flushing. The sensation concentrates around the head, neck, chest, and upper back. When these episodes happen during sleep, they’re called night sweats, which can be disruptive enough to fragment sleep for months or years. VMS are the only symptom that has been clearly and directly linked to menopause itself, even though mood changes, difficulty concentrating, and irritability often get lumped in.
Why They Happen
Your brain has a built-in thermostat, a cluster of neurons in the hypothalamus that keeps your body temperature within a narrow comfortable range. When estrogen levels drop during menopause, a specific group of these neurons (sometimes called KNDy neurons) becomes dysregulated. They start overreacting to small temperature changes, interpreting a normal body temperature as too hot. The brain then triggers a cooling response: blood vessels near the skin dilate rapidly, you flush, and you sweat. The whole cascade is your body trying to dump heat it doesn’t actually need to lose.
This is why VMS are tied so closely to the timing of menopause. They typically begin during perimenopause, when estrogen levels start fluctuating unpredictably, and they can continue well into postmenopause as the body adjusts to a new hormonal baseline.
How Long VMS Last
One of the biggest surprises for many women is how long VMS persist. Clinical guidelines have historically underestimated the timeline. A major longitudinal study found the median total duration of frequent VMS is 7.4 years, with symptoms continuing for about 4.5 years after a woman’s final menstrual period.
The timing of when symptoms first appear matters. Women who start experiencing frequent VMS while still premenopausal or in early perimenopause tend to have the longest course, with a median duration exceeding 11.8 years and symptoms persisting about 9.4 years after their last period. Women whose VMS don’t begin until after menopause tend to have a shorter course, around 3.4 years.
Race also plays a role. African American women report the longest total VMS duration, with a median of 10.1 years. The reasons aren’t fully understood but likely involve a combination of genetic, physiological, and socioeconomic factors.
The Cardiovascular Connection
VMS aren’t just uncomfortable. Their severity appears to be a marker for cardiovascular risk. A pooled analysis of six large prospective studies found that women with severe hot flashes had an 83% higher risk of cardiovascular disease compared to women without symptoms. Severe night sweats carried a 59% higher risk. Women who reported severe versions of both had roughly double the cardiovascular risk.
Interestingly, it was the severity of symptoms, not how often they occurred, that tracked most closely with heart disease risk. Frequent night sweats did show a dose-response relationship with cardiovascular events, but for hot flashes, frequency alone wasn’t a reliable predictor. The takeaway: if your VMS are intense rather than just frequent, that’s worth paying attention to as part of your broader health picture.
Hormone Therapy for VMS
Hormone therapy remains the most effective treatment for VMS. Standard-dose regimens reduce symptoms by about 75%, while lower-dose options achieve around 65% reduction. Current guidelines recommend it for healthy postmenopausal women who are 60 or younger and within 10 years of menopause. The greatest benefit comes from starting during perimenopause or within the first decade after the final period.
For women who experience premature ovarian insufficiency (menopause before 40) or early menopause (before 45), hormone therapy is recommended regardless of whether symptoms are present, because the early loss of estrogen carries long-term risks for bone health and other systems.
Non-Hormonal Treatment Options
Not every woman can or wants to use hormone therapy. A newer class of medication works by targeting the brain’s thermostat directly. These drugs block a chemical messenger called neurokinin B from reaching its receptor in the hypothalamus, calming the overactive neurons that trigger hot flashes. In clinical trials, women taking this type of medication experienced a 75% to 90% reduction in the frequency of their VMS by 12 weeks, compared to a 55% reduction with placebo. This option is particularly relevant for women with a history of hormone-sensitive cancers or blood clots who can’t safely use estrogen.
Diet, Weight, and Lifestyle
Body composition has a consistent relationship with VMS. Multiple studies have found that women with a higher body mass index or greater body fat percentage report more frequent and more severe symptoms. Weight gain is associated with worsening VMS, while weight loss is associated with improvement. In one trial, women who lost weight over the course of a year were more likely to reduce or eliminate their hot flashes and night sweats compared to those who maintained their weight.
Dietary patterns also seem to matter. A large trial through the Women’s Health Initiative tested a diet lower in fat (about 20% of calories from fat) with more fruits, vegetables, and whole grains. Women following this pattern were significantly more likely to eliminate their VMS. By the end of the first year, the intervention group was eating nearly twice the fiber, more fruits and vegetables, and substantially less fat than the control group. Higher fiber intake and lower fat intake have both been independently linked to reduced VMS in observational research.
Common triggers that can provoke individual episodes include alcohol, caffeine, spicy foods, hot beverages, and warm environments, though sensitivity to these varies widely from person to person. Tracking your own triggers can help you identify which ones matter most for you.